US Patent Issued to AstraZeneca on July 22 for "Dosage regimen for the treatment of cancer" (British, American Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,689, issued on July 22, was assigned to AstraZeneca AB (Sodertalje, Sweden).

"Dosage regimen for the treatment of cancer" was invented by Pablo Morentin Gutierrez (Cambridge, Great Britain), Camila De Almeida (Cambridge, Great Britain) and Eric Todd Gangl (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present specification relates to AZD9833 for use in the treatment of cancer and methods of treatment of cancer involving administration of AZD9833 wherein, in each case, the AZD9833 is administered orally once daily at a dose between 25 mg and 450 mg. AZD9833 may be administered alone or its use may be in combination with an additio...